← All indications
Mixed Tumor, Mullerian
A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. (Holland et al., Cancer Medicine, 3d ed, p1703)
Drugs by status
Phase 2 trials (2)
Organizations
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (38)
- Takeda
- Bristol-Myers Squibb
- Clovis Oncology
- AstraZeneca
- Merck
- Genentech
- Sanofi
- GlaxoSmithKline
- Leap Therapeutics, Inc.
- Syndax Pharmaceuticals
- Zymeworks Inc.
- The Christie NHS Foundation Trust
- Medical University of Graz
- Cornell University
- Harvard University
- Medical College of Wisconsin
- North Eastern Germany Society of Gynaecologic Oncology
- Southwest Oncology Group
- Thomas Jefferson University
- University of Manchester
- University of Milan
- University of Oklahoma
- University of Toronto
- Mayo Clinic
- Cardiff University
- University of Chicago
- Vanderbilt University
- University of Texas at Houston
- University of Duisburg-Essen
- University of Alabama, Birmingham
- +8 more
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)